Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetP2Y purinoceptor 4
LigandBDBM50013028
Substrate/Competitorn/a
Meas. Tech.ChEMBL_1351703 (CHEMBL3270103)
EC50 200±n/a nM
Citation Jayasekara, PSBarrett, MOBall, CBBrown, KAHammes, EBalasubramanian, RHarden, TKJacobson, KA 4-Alkyloxyimino derivatives of uridine-5'-triphosphate: distal modification of potent agonists as a strategy for molecular probes of P2Y2, P2Y4, and P2Y6 receptors. J Med Chem57:3874-83 (2014) [PubMed]  Article
More Info.:Get all data from this article,  Assay Method
 
P2Y purinoceptor 4
Name:P2Y purinoceptor 4
Synonyms:NRU | P2P | P2RY4 | P2RY4_HUMAN | P2Y purinoceptor 4 | P2Y4 | Pyrimidinergic receptor P2Y4 | UNR | Uridine nucleotide receptor
Type:PROTEIN
Mol. Mass.:40977.17
Organism:Homo sapiens (Human)
Description:ChEMBL_751027
Residue:365
Sequence:
MASTESSLLRSLGLSPGPGSSEVELDCWFDEDFKFILLPVSYAVVFVLGLGLNAPTLWLF
IFRLRPWDATATYMFHLALSDTLYVLSLPTLIYYYAAHNHWPFGTEICKFVRFLFYWNLY
CSVLFLTCISVHRYLGICHPLRALRWGRPRLAGLLCLAVWLVVAGCLVPNLFFVTTSNKG
TTVLCHDTTRPEEFDHYVHFSSAVMGLLFGVPCLVTLVCYGLMARRLYQPLPGSAQSSSR
LRSLRTIAVVLTVFAVCFVPFHITRTIYYLARLLEADCRVLNIVNVVYKVTRPLASANSC
LDPVLYLLTGDKYRRQLRQLCGGGKPQPRTAASSLALVSLPEDSSCRWAATPQDSSCSTP
RADRL
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM50013028
n/a
NameBDBM50013028
Synonyms:CHEMBL3261377
TypeSmall organic molecule
Emp. Form.C63H89N12O27P3S2
Mol. Mass.1603.496
SMILESCC[NH+](CC)CC.CC[NH+](CC)CC.Nc1ccc2c(-c3ccc(cc3C([O-])=O)C(=O)NCCCCCCn3cc(CCNC(=O)COc4ccc(CCCO\N=c5\ccn([C@@H]6O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]6O)c(=O)[nH]5)cc4)nn3)c3ccc(=[NH2+])c(c3oc2c1S([O-])(=O)=O)S([O-])(=O)=O |r,wU:63.62,61.59,wD:78.77,80.80,(35.71,-3.26,;34.38,-4.03,;33.04,-3.26,;31.71,-4.03,;30.37,-3.26,;33.04,-1.72,;34.38,-.95,;21.75,-2.15,;20.41,-2.92,;19.08,-2.15,;17.74,-2.92,;16.41,-2.15,;19.08,-.61,;20.41,.16,;40.87,-7.81,;42.41,-7.81,;43.19,-9.15,;44.72,-9.15,;45.49,-7.83,;47.02,-7.83,;47.79,-9.16,;47.02,-10.5,;47.79,-11.83,;49.32,-11.82,;50.1,-10.5,;49.33,-9.16,;50.1,-7.83,;51.64,-7.83,;48.56,-7.82,;50.09,-13.16,;51.63,-13.16,;49.32,-14.49,;47.78,-14.49,;47.01,-15.82,;45.47,-15.82,;44.7,-14.48,;43.16,-14.48,;42.39,-13.15,;40.85,-13.15,;39.95,-11.9,;38.47,-12.38,;37.14,-11.61,;35.81,-12.37,;34.48,-11.6,;33.14,-12.36,;33.13,-13.9,;31.81,-11.59,;31.81,-10.05,;30.48,-9.27,;29.14,-10.03,;27.82,-9.26,;27.83,-7.72,;26.5,-6.94,;25.17,-7.7,;23.84,-6.93,;22.5,-7.69,;21.17,-6.91,;19.83,-7.68,;18.5,-6.9,;17.17,-7.67,;17.16,-9.22,;15.69,-9.69,;14.49,-8.82,;13.23,-9.73,;11.77,-9.25,;11.73,-7.73,;10.38,-6.99,;10.34,-5.45,;10.37,-8.53,;9.07,-7.8,;7.72,-7.06,;7.68,-5.52,;7.7,-8.59,;6.39,-7.86,;5.04,-7.11,;3.72,-7.91,;5.01,-5.57,;5.02,-8.65,;13.69,-11.2,;12.79,-12.43,;15.23,-11.2,;16.14,-12.43,;18.49,-9.99,;18.49,-11.52,;19.84,-9.22,;29.16,-6.95,;30.49,-7.72,;38.48,-13.92,;39.94,-14.39,;47.8,-6.5,;49.33,-6.49,;50.1,-5.18,;49.34,-3.84,;50.12,-2.51,;47.8,-3.83,;47.03,-5.16,;45.49,-5.15,;44.73,-6.49,;43.19,-6.48,;42.43,-5.15,;43.2,-3.82,;41.1,-4.37,;41.09,-5.91,;47.04,-2.5,;47.81,-1.17,;45.7,-1.72,;45.7,-3.26,)|
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: